Page last updated: 2024-09-05

repinotan hydrochloride and Acute Disease

repinotan hydrochloride has been researched along with Acute Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lutsep, HL	1

Reviews

1 review(s) available for repinotan hydrochloride and Acute Disease

Article	Year
Repinotan, A 5-HT1A agonist, in the treatment of acute ischemic stroke. Current drug targets. CNS and neurological disorders, 2005, Volume: 4, Issue:2 Topics: Acute Disease; Aged; Benzopyrans; Brain Ischemia; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Neuroprotective Agents; Serotonin Receptor Agonists; Stroke; Thiazoles; Treatment Outcome	2005

Article

Year

Repinotan, A 5-HT1A agonist, in the treatment of acute ischemic stroke.

Current drug targets. CNS and neurological disorders, 2005, Volume: 4, Issue:2

Topics: Acute Disease; Aged; Benzopyrans; Brain Ischemia; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Neuroprotective Agents; Serotonin Receptor Agonists; Stroke; Thiazoles; Treatment Outcome

2005